We are only able to display limited information for this firm. We display more complete information for all of the following firms:
Demonstrating extensive expertise across the pharma, tech, and real estate industries, the O'Melveny practice is highly regarded for handling complex cross-border takeovers and joint venture transactions. Operating out of Beijing, co-head Ke Geng routinely advises clients in connection with financings for Chinese companies, M&A, and other corporate issues, while in Hong Kong, Nima Amini predominantly focuses on assisting private equity funds and finance institutions. The team also frequently manages multi-jurisdictional investments.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- 'The OMM team in Shanghai is extremely responsive. As a multinational company headquartered in Europe, OMM's key strength for us is their cultural and language fluency, especially their ability to explain the Chinese legal landscape to our legal colleagues at headquarters in a way that they can understand.'
- 'Walker Wallace has the linguistic and cultural fluency needed to help senior management outside China to appreciate the legal landscape in China. He is a veteran lawyer with decades of experience in China.'
Abbreviated data is displayed for this firm.
Work highlights
- Represented Acotec Scientific on the voluntary partial offer by Boston Scientific Group, the first takeover offer made to a biotech company listed under Chapter 18A of the Hong Kong Listing Rules; also reported to be the largest Hong Kong public M&A transaction in the Chinese medical industry since 2014.
Abbreviated data is displayed for this firm.